
Therapeutics Pipeline 2024 Laura Sauer; Alice Sato; Herbert Davies PMID: 38754937DOI: https://doi.org/10.1016/j.pcl.2024.03.002 Access Resources Journal ArticleEN Ask aRCie About This Resource About Kids have different needs and vulnerabilities compared to adults, which makes it hard to create treatments for them. This becomes even more challenging during a pandemic. In the past ten years, there have been improvements in making medicines for children, especially because of the COVID-19 pandemic. It's crucial to have a system in place to develop medicines specifically for children. This article is part of a series in Pediatrics Clinics of North America 2024 June; 71(3). Tags Focus Area: Infectious Disease Audience: Physicians Emergency Management Stage: Preparedness (Prevention / Protection) Keywords: Physiology; Therapeutics; Pandemics; COVID-19; SARS-CoV-2; COVID-19 Drug Treatment Institutions: University of Nebraska Medical Center More like this Infection Prevention and Control Implications of Special Pathogens in Children 2024 · Northwestern University, Emory University, University of Nebraska Medical Center, Seattle Children's Hospital, University of Washington Diagnosis, Treatment, and Prevention of Monkeypox in Children: An Experts’ Consensus Statement 2023 · Capital Medical University, Shenzhen Children's Hospital, Chinese Center for Disease Control and Prevention, Chinese Academy of Medical Science & Peking Union Medical College, Beijing Children's Hospital Chemical-Biological Terrorism and Its Impact on Children [2020] 2020 · Harvard Medical School, Boston Children's Hospital, Yale University, Children's Hospital Colorado, University of Colorado, American Academy of Pediatrics (AAP) The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Access Resources Journal ArticleEN Ask aRCie About This Resource

Therapeutics Pipeline

2024
Laura Sauer; Alice Sato; Herbert Davies

PMID: 38754937DOI: https://doi.org/10.1016/j.pcl.2024.03.002

Access Resources

About

Kids have different needs and vulnerabilities compared to adults, which makes it hard to create treatments for them. This becomes even more challenging during a pandemic. In the past ten years, there have been improvements in making medicines for children, especially because of the COVID-19 pandemic. It's crucial to have a system in place to develop medicines specifically for children. This article is part of a series in Pediatrics Clinics of North America 2024 June; 71(3).

More like this

Infection Prevention and Control Implications of Special Pathogens in Children 2024 · Northwestern University, Emory University, University of Nebraska Medical Center, Seattle Children's Hospital, University of Washington Diagnosis, Treatment, and Prevention of Monkeypox in Children: An Experts’ Consensus Statement 2023 · Capital Medical University, Shenzhen Children's Hospital, Chinese Center for Disease Control and Prevention, Chinese Academy of Medical Science & Peking Union Medical College, Beijing Children's Hospital Chemical-Biological Terrorism and Its Impact on Children [2020] 2020 · Harvard Medical School, Boston Children's Hospital, Yale University, Children's Hospital Colorado, University of Colorado, American Academy of Pediatrics (AAP)

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Therapeutics Pipeline

Access Resources

About

Tags

More like this

Access Resources